Avertix Medical, Inc. · CIK 1564031
Avertix Medical, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
1
Amendments
1
Activity
Mar 11, 2025
through Sep 23, 2025
through Sep 23, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Mar 11, 2025 · D/A | Sep 23, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $22,650,000 | $5,000,000 | $-17,650,000 |
| Reported amount sold | $14,253,772 | $1,011,667 | $-13,242,105 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001564031-25-000001 · Later SEC source: 0002080612-25-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $5,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $1,011,667
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0002080612-25-000002D · Sep 23, 2025 · Other Health CareOffering: $5,000,000Sold: $1,011,667
Compared with 0001564031-25-000001:
- Reported offering amount: $22,650,000 → $5,000,000
- Reported amount sold: $14,253,772 → $1,011,667
-
0001564031-25-000001D/A · Mar 11, 2025 · Other Health CareOffering: $22,650,000Sold: $14,253,772